- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Services
- Sub-Industry: Medical-Hospitals
Avita Medical Ltd
+ Add to WatchlistAVMXF:US
0.1250 USD 0.00000.00%As of 20:10:00 ET on 05/23/2013.
Snapshot for Avita Medical Ltd (AVMXF)
| Open: | - | Day's Range: | - | Volume: | 7,500 |
|---|---|---|---|---|---|
| Previous Close: | 0.1250 | 52wk Range: | 0.0800 - 0.2400 | 1-Yr Rtn: | -47.92% |
Key Statistics for AVMXF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (AUD) (ttm) | - |
| Est. EPS (AUD) (06/2013) | -0.0290 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 20,964 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for AVMXF
Company Profile & Key Executives for AVMXF
Avita Medical Limited is a biotechnology company which develops and distributes tissue-engineered cellular products for skin replacement. The Company's products include CellSpray and ReCell, which are used for the treatment of burns and other skin injuries, previous scarring, chronic wounds and cosmetic procedures.
| William Ford DolphinCEO/Managing Director | Timothy Rooney "Tim"CFO/COO |
| William MarshallVP:Operations | Andrew QuickVP:Research & Technology |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
AVMXF News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page